Showing results (221-230 of 376) with videos related to

Sort By:
Pageof 38
Antiviral Therapy|February 4, 2012
Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapyArkaitz Imaz, Montserrat Olmo, Maria Peñaranda, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 2025
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trialElisa de Lazzari, Silvana Di Gregorio, Jhon Rojas, et al.
Plos One|August 8, 2024
Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaintsNicholas Grunden, Marco Calabria, Carmen García-Sánchez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapyJuan Berenguer, Pilar Miralles, Julio Arrizabalaga, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2007
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosisEsteban Ribera, Carlos Azuaje, Rosa M Lopez, et al.
Current HIV Research|November 26, 2009
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, SpainBeatriz Mothe, Iñaki Perez, Pere Domingo, et al.
International Journal of Molecular Sciences|July 28, 2022
Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy InitiationJenifer Masip, Rosa Jorba, Miguel López-Dupla, et al.
AIDS Research and Human Retroviruses|July 14, 2010
Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trialJosé M Miró, Christian Manzardo, Judith Pich, et al.
AIDS (London, England)|December 6, 2024
Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic IslandsAndreu Bruguera, Daniel K Nomah, Sergio Moreno-Fornés, et al.
Journal of Clinical Medicine|February 15, 2022
Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral TherapyPere Domingo, María Gracia Mateo, Joan Villarroya, et al.
Pageof 38